<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Fabrication, drug delivery kinetics and cell viability assay of PLGA-coated vancomycin-loaded silicate porous microspheres - Health AI Hub</title>
    <meta name="description" content="This paper introduces PLGA-coated porous Mg-Ca silicate microspheres (diopside, bredigite, akermanite) loaded with vancomycin, designed for controlled drug rele">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Fabrication, drug delivery kinetics and cell viability assay of PLGA-coated vancomycin-loaded silicate porous microspheres</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.20065v1" target="_blank">2512.20065v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-23
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> N. Zirak, A. Maadani, E. Salahinejad, N. Abbasnezhad, M. Shirinbayan
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> physics.med-ph, cond-mat.mtrl-sci, physics.app-ph, physics.bio-ph, physics.chem-ph
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 0.98 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.20065v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.20065v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces PLGA-coated porous Mg-Ca silicate microspheres (diopside, bredigite, akermanite) loaded with vancomycin, designed for controlled drug release and bone tissue applications. It demonstrates that PLGA coating significantly reduces drug burst release, improves cytocompatibility, and dominates drug diffusion kinetics, with akermanite-based microspheres showing the most promising biocompatibility.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is highly relevant to medicine as it offers a novel approach for localized, sustained antibiotic delivery within bone regeneration scaffolds, which can prevent or treat infections common in orthopedic and dental implants, thereby improving healing outcomes and reducing systemic drug side effects.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>None. While a 'sequential quadratic programming algorithm method' is mentioned for analyzing drug release mechanisms, this is a mathematical optimization technique used for data analysis rather than an AI application in the typical sense of medical AI (e.g., machine learning for diagnosis, predictive analytics, or intelligent systems for healthcare).</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Mg-Ca silicate powders (diopside, bredigite, akermanite) were synthesized via sol-gel and calcination methods.</li>
                    
                    <li>Porous microspheres (700-1000 um diameter) were fabricated using carbon porogen, droplet extrusion, and sintering, then loaded with vancomycin and coated with PLGA.</li>
                    
                    <li>PLGA coating successfully mitigated the significant burst release of vancomycin observed from bare microspheres into a physiological medium.</li>
                    
                    <li>Drug release mechanisms were analyzed, revealing that PLGA coating dominates the diffusion mechanism, with varying diffusion contributions among different silicate types (diopside > akermanite > bredigite).</li>
                    
                    <li>Cell viability (MTT assay with dental pulp stem cells) indicated that drug loading initially deteriorated biocompatibility, but PLGA coating significantly improved it.</li>
                    
                    <li>PLGA-coated akermanite microspheres exhibited the highest biocompatibility (ranked akermanite > diopside > bredigite), attributed to a balanced release of ceramic ions and vancomycin.</li>
                    
                    <li>The developed PLGA-coated Mg-Ca silicate microspheres are identified as promising candidates for drug-delivery in bone tissue engineering and dental bone grafting applications.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>Mg-Ca silicate powders (diopside, bredigite, akermanite) were synthesized via sol-gel and calcination. Porous microspheres (700-1000 um) were then fabricated using carbon porogen, droplet extrusion, and sintering techniques. These microspheres were loaded with vancomycin hydrochloride and subsequently coated with poly (lactic-co-glycolic acid) (PLGA). Drug release kinetics in a physiological medium were studied, and the contributions of burst, degradation, and diffusion mechanisms were quantified using a sequential quadratic programming algorithm. Cell cytocompatibility was assessed via an MTT assay using dental pulp stem cells.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>Bare silicate microspheres demonstrated significant burst release, which was effectively mitigated by PLGA coating. PLGA coating was found to be the dominant factor governing drug diffusion kinetics. The relative contribution of diffusion to bioresorption was ranked as diopside > akermanite > bredigite. While drug loading initially reduced cell viability, PLGA coating substantially improved the cytocompatibility. PLGA-coated akermanite microspheres exhibited superior biocompatibility compared to diopside and bredigite, attributed to an optimal balance in the release of ceramic ions and vancomycin.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This technology holds significant promise for clinical applications by enabling targeted, sustained antibiotic delivery at bone repair sites, potentially reducing surgical site infections, treating osteomyelitis, and enhancing bone regeneration in orthopedic and dental procedures. The controlled release and improved biocompatibility could lead to better patient outcomes with fewer systemic side effects associated with conventional antibiotic administration.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state study limitations. However, typical limitations for such in-vitro studies often include the lack of in-vivo validation, long-term degradation analysis under physiological conditions, and comprehensive toxicology studies beyond initial cell viability assays.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>While not explicitly stated, the conclusion that these are "promising candidates" implies future research should focus on in-vivo studies in animal models to evaluate efficacy, long-term safety, degradation profiles, and bone regenerative capacity. Further optimization of drug loading and coating parameters, alongside detailed mechanistic studies on cellular interactions and immune responses, would also be crucial for clinical translation.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Orthopedic Surgery</span>
                    
                    <span class="tag">Dentistry</span>
                    
                    <span class="tag">Regenerative Medicine</span>
                    
                    <span class="tag">Infectious Disease (prevention in surgery)</span>
                    
                    <span class="tag">Biomaterials Science</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Vancomycin</span>
                    
                    <span class="tag tag-keyword">PLGA</span>
                    
                    <span class="tag tag-keyword">Silicate microspheres</span>
                    
                    <span class="tag tag-keyword">Drug delivery</span>
                    
                    <span class="tag tag-keyword">Bone tissue engineering</span>
                    
                    <span class="tag tag-keyword">Biocompatibility</span>
                    
                    <span class="tag tag-keyword">Controlled release</span>
                    
                    <span class="tag tag-keyword">Akermanite</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Porous ceramic microspheres are a desirable substance for bone tissue reconstruction and delivery applications. This study focuses on Mg-Ca silicate microspheres encapsulated in biodegradable poly (lactic-co-glycolic acid) (PLGA) to serve as a biocompatible carrier for the controlled release of vancomycin hydrochloride. In this regard, diopside (MgCaSi2O6), bredigite (MgCa7Si4O16) and akermanite (MgCa2Si2O7) powders were synthesized by sol-gel and subsequent calcination methods. Then, porous akermanite, diopside and bredigite microspheres of 700-1000 um in diameter were fabricated by using carbon porogen, droplet extrusion and sintering, then loaded with the drug and eventually coated with PLGA. The bare microspheres showed a considerable burst release mode of the drug into a physiological medium, whereas PLGA coating of the microspheres reduced the burst release level. To investigate effective mechanisms governing in the drug release from the carriers, the contribution of burst, degradation, and diffusion was analyzed by the sequential quadratic programming algorithm method. It was found that the relative contribution of diffusion to bioresorption is ranked as diopside > akermanite > bredigite, whereas PLGA coating dominates the diffusion mechanism. The dental pulp stem cells cytocompatibility MTT assay of the microspheres also showed that the drug loading deteriorates but PLGA coating improves the cell biocompatibility significantly. Comparatively, the biocompatibility of the PLGA-coated microspheres was ranked as akermanite > diopside > bredigite, as a result of a compromise between the release of the constituting ions of the ceramic carriers and vancomycin molecules. It was eventually concluded that PLGA-coated Mg-Ca silicate microspheres are promising candidates for drug-delivery bone tissue engineering and dental bone grafting applications.</p>
            </section>

            

            
            <section class="paper-section">
                <h2>Journal Reference</h2>
                <p>Ceramics International, 48 (2022) 48-54</p>
            </section>
            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>